Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.

@article{Ersz2006SubcutaneousLA,
  title={Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.},
  author={Halil {\"o}nder Ers{\"o}z and Kubilay Ukinç and Mehmet Metin K{\"o}se and Cihangir Erem and Aytac Gunduz and Arif Bayram Hacihasanoğlu and S. Sami Karti},
  journal={International journal of clinical practice},
  year={2006},
  volume={60 4},
  pages={
          429-33
        }
}
In this prospective, randomised, open trial, we wanted to evaluate the efficacy and safety of hourly subcutaneous (SC) insulin lispro administration in the treatment of diabetic ketoacidosis (DKA) in comparison with intravenous (IV) regular insulin treatment. Twenty patients were enrolled in the study. The patients were randomly assigned into two groups. Following a bolus injection of 0.15 U/kg IV regular insulin, group L received half of this dose as hourly SC insulin lispro while group R was… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS